Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Merz Therapeutics Nordics AB
AB
Active
Org 5593735805
Gustav Iii:S Boulevard 32, 169 73
Solna
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2022
15 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Merz Therapeutics Nordics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
39M
78M
116M
155M
0M
2023
84M
2024
135M
2025
EBITDA
SEK millions
0M
2M
4M
6M
8M
1M
2023
6M
2024
7M
2025
Income statement
SEK thousands
Item
2023
2024
2025
Revenue
0
84 271
134 661
Staff expenses
—
—
−31 285
EBITDA
503
6 198
7 384
Depreciation & amort.
−2
−551
−688
EBIT
501
5 647
6 696
Net financials
−261
−482
−26
Profit before tax
241
5 166
6 671
Tax
−73
−1 170
−1 514
Net profit
168
3 996
5 157
Balance sheet
SEK thousands
Item
2023
2024
2025
Total assets
28 332
43 618
80 375
Equity
5 793
9 788
14 945
Long-term debt
16 700
0
—
Short-term debt
5 839
33 829
65 430
Total debt
22 539
33 829
65 430
Financial ratios
5-year trend
EBITDA margin
5.5%
This company
15.8%
Market median
-65% vs market
2023
2025
Equity ratio
18.6%
This company
38.2%
Market median
-51% vs market
2023
2025
Return on equity
34.5%
This company
18.4%
Market median
+88% vs market
2023
2025
Net profit margin
3.8%
This company
8.1%
Market median
-53% vs market
2023
2025
Asset turnover
1.68×
This company
1.12×
Market median
+50% vs market
2023
2025
Debt / equity
4.38×
This company
0.62×
Market median
-606% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-03-01 – 2023-06-30
View
PDF
More on Merz Therapeutics Nordics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
